What is Shadow AI and How is it Impacting Pharma Companies? | PharmExec
Aravo CCO Dave Rusher discusses the risk of third-party AI usage at pharma companies.
Read the original at Pharmaceutical Executive ↗
- Topics
- Shadow AIHealthcare
- Tracked via
- “shadow ai”